Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT02217657
Eligibility Criteria:
Inclusion Criteria:
* Patients with symptomatic atrial fibrillation and additional substrate modification or perimitral flutter
* Patients with persistent atrial fibrillation
* Patients with perimitral flutter
* Patients with recurrence after a circumferential PV isolation procedure
* Patients with paroxysmal atrial fibrillation and AF episodes lasting \> 7 days
* Patients (\>18 und \<80 Jahre)
Exclusion Criteria:
* moderate to severe valvular heart disease,
* congenital heart disease
* reduced left ventricular function (ejection fraction \<35%)
* any reversible cause for atrial fibrillation (e.g. hyperthyroidism)
* intracardiac thrombi documented by transesophageal echocardiography
* myocardial infarction within 3 months, cardiac surgery in the previous three months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02217657
Study Brief:
Protocol Section:
NCT02217657